New Report Shows Pla
New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
November 19, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Late last week the International Diabetes Federation (IDF) released a report filled with some staggering statistics in the fight against diabetes....
Plandai Biotechnolog
Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
November 14, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 14, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) and its subsidiary, Cannabis Biosciences, Inc., received a strong validation for their move into medical...
Plandai Biotechnolog
Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract
October 30, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 30, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Involved in Numerous Clinical Trials as Company Prepares Products for Market
October 03, 2013 09:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) has several clinical trials already underway, and a host of others scheduled to commence in the company...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Enters Fourth Quarter Stronger Than Ever With Pheroid(TM) Technology
October 02, 2013 08:45 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 2, 2013) - Plandaí Biotechnology Inc. (OTCQB: PLPL) already has a technology in place that is allowing it to boast of higher bioavailability with its...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces New Extract in Its Ongoing Fight Against Malaria
October 01, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 1, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Buy Rating and New R
Buy Rating and New Report Issued for Plandai Biotechnology, Inc.
September 23, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 23, 2013) - Stock Market Media Group, a research and content development investor relations firm, has released its 3rd Quarter report and issued a Speculative Buy...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Commencement of Clinical Trials Using Phytofare Topical Product
September 05, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 5, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnolog
Plandai Biotechnology, Inc.'s Phytofare Could Address Growing Diabetes Numbers
September 04, 2013 13:53 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) is already hard at work in Africa to develop a treatment for malaria, and it may just have a product in its...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Completion of Production Facility, Installation of Equipment to Commence
September 04, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...